Terveystalo revenue and financials
€7.14Change from previous close: −4.55%Absolute change: −€0.34
In the fiscal year ended December 2025, Terveystalo reported revenue of €1.28B (−4.56% year over year). Net income was €92.6M, a net margin of 7.2%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- −4.56%
- 2025 vs 2024
- Net income growth
- +29.15%
- 2025 vs 2024
- Net margin
- 7.2%
- 2024: 5.4%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 207 | 224 | 158 | 141 | — |
| Depreciation and amortization | 95.9 | 102 | 107 | 103 | — |
| Capital expenditure | -51.6 | -39.6 | -41.0 | -59.2 | — |
| Investing cash flow | -69.6 | -47.4 | -44.2 | -93.9 | — |
| Financing cash flow | -127 | -149 | -116 | -44.6 | — |
| Dividends paid | -60.8 | -38.0 | -35.4 | -35.4 | — |
| Share repurchases | — | — | — | 0.0 | -11.3 |
| Debt issued | 18.1 | 210 | 251 | 211 | — |
| Debt repaid | -15.6 | -245 | -257 | -157 | — |
| Effect of exchange rates | 0.1 | -0.1 | -0.1 | -0.3 | — |
| Net change in cash | 10.6 | 27.5 | -2.4 | 2.4 | — |
| Free cash flow | 155 | 184 | 117 | 81.7 | — |